Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
QHSLab ( (USAQ) ) has issued an update.
On November 18, 2025, QHSLab, Inc. completed a Note Repurchase Agreement to retire over $1.4 million in defaulted convertible debt, originally issued in 2021 and 2022, for a cash payment of $300,000. This strategic move strengthens QHSLab’s balance sheet, reduces future dilution risks, and eliminates conversion rights, positioning the company for healthier financial growth. The company reported a 35% increase in Q3 2025 revenue, reflecting strong operational momentum and effective technology deployment in primary care settings.
Spark’s Take on USAQ Stock
According to Spark, TipRanks’ AI Analyst, USAQ is a Neutral.
USA Equities receives a modest score due to significant financial challenges, including negative equity and profitability issues, despite robust revenue growth and cash flow improvements. The mixed technical indicators and negative valuation metrics further weigh down the score. However, the score is bolstered by positive corporate events, including strategic partnerships and record revenue growth, highlighting potential for future success.
To see Spark’s full report on USAQ stock, click here.
More about QHSLab
QHSLab, Inc. (OTCQB: USAQ) is a digital health technology leader providing preventive screening, assessment, and workflow solutions for primary care. Its tools help practices identify, document, and manage underdiagnosed chronic and behavioral conditions efficiently and profitably.
Average Trading Volume: 16,456
Technical Sentiment Signal: Strong Sell
Current Market Cap: $1.85M
For detailed information about USAQ stock, go to TipRanks’ Stock Analysis page.